{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:16Z","timestamp":1792788256567,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82401294"],"award-info":[{"award-number":["82401294"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project","award":["2025KY426"],"award-info":[{"award-number":["2025KY426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04775-7","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:43:36Z","timestamp":1783687416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Size-shrinking nanoparticles with high drug-protein payload for efficient, non-invasive treatment of corneal neovascularization"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaoling","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"4775_CR1","doi-asserted-by":"publisher","first-page":"108363","DOI":"10.1016\/j.exer.2020.108363","volume":"202","author":"MP Nicholas","year":"2021","unstructured":"Nicholas MP, Mysore N. Corneal neovascularization. Exp Eye Res. 2021;202:108363\u20139.","journal-title":"Exp Eye Res"},{"issue":"3","key":"4775_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43(3):245\u201369.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"4775_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","volume":"16","author":"D Roshandel","year":"2018","unstructured":"Roshandel D, et al. Current and emerging therapies for corneal neovascularization. Ocul Surf. 2018;16(4):398\u2013414.","journal-title":"Ocul Surf"},{"issue":"2","key":"4775_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","volume":"10","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, et al. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf. 2012;10(2):67\u201383.","journal-title":"Ocul Surf"},{"key":"4775_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jtos.2023.08.001","volume":"30","author":"S Kaur","year":"2023","unstructured":"Kaur S, et al. Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery. Ocul Surf. 2023;30:3\u201313.","journal-title":"Ocul Surf"},{"issue":"3","key":"4775_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11(3):866\u201393.","journal-title":"Drug Deliv Transl Res"},{"key":"4775_CR7","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.2147\/IJN.S532074","volume":"20","author":"X Lin","year":"2025","unstructured":"Lin X, et al. Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases. Int J Nanomed. 2025;20:9221\u201349.","journal-title":"Int J Nanomed"},{"issue":"30","key":"4775_CR8","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1021\/acs.nanolett.5c02761","volume":"25","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, et al. Biomimetic Metal-Organic Antioxidant Eye Drops for Corneal Neovascularization: Visible-Light-Triggered CO Release for Microenvironment Regulation. Nano Lett. 2025;25(30):11703\u201312.","journal-title":"Nano Lett"},{"issue":"1","key":"4775_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12951-024-02510-8","volume":"22","author":"H Wu","year":"2024","unstructured":"Wu H, et al. A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment for corneal neovascularization. J Nanobiotechnol. 2024;22(1):290.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4775_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular Drug Delivery: a Comprehensive Review. AAPS PharmSciTech. 2023;24(2):66.","journal-title":"AAPS PharmSciTech"},{"key":"4775_CR11","doi-asserted-by":"publisher","first-page":"124799","DOI":"10.1016\/j.ijpharm.2024.124799","volume":"666","author":"K \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk K, Kaplan M, \u00c7al\u0131\u015f S. Effects of nanoparticle size, shape, and zeta potential on drug delivery. Int J Pharm. 2024;666:124799.","journal-title":"Int J Pharm"},{"issue":"4","key":"4775_CR12","first-page":"444","volume":"16","author":"J Di","year":"2021","unstructured":"Di J, et al. Size, shape, charge and stealthy surface: Carrier properties affect the drug circulation time in vivo. Asian J Pharm Sci. 2021;16(4):444\u201358.","journal-title":"Asian J Pharm Sci"},{"key":"4775_CR13","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770.","journal-title":"Adv Drug Deliv Rev"},{"key":"4775_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","volume":"353","author":"J Xu","year":"2023","unstructured":"Xu J, et al. Applications and challenges of ultra-small particle size nanoparticles in tumor therapy. J Control Release. 2023;353:699\u2013712.","journal-title":"J Control Release"},{"key":"4775_CR15","doi-asserted-by":"crossref","unstructured":"Beirampour N et al. Formulation of Polymeric Nanoparticles Loading Baricitinib as a Topical Approach in Ocular Application. Pharmaceutics 2024;16(8):1092.","DOI":"10.3390\/pharmaceutics16081092"},{"key":"4775_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","volume":"248","author":"A Mandal","year":"2017","unstructured":"Mandal A, et al. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies. J Control Release. 2017;248:96\u2013116.","journal-title":"J Control Release"},{"issue":"2","key":"4775_CR17","doi-asserted-by":"publisher","first-page":"e1848","DOI":"10.1002\/wnan.1848","volume":"15","author":"Z Lu","year":"2023","unstructured":"Lu Z, et al. Activated aggregation strategies to construct size-increasing nanoparticles for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(2):e1848.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"42","key":"4775_CR18","doi-asserted-by":"publisher","first-page":"37065","DOI":"10.1021\/acsnano.5c10610","volume":"19","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. Highly Efficient Intrastromal Dual-Drug Delivery by a Dissolving Bilayer Microneedle for Synergistic Therapy against Corneal Neovascularization. ACS Nano. 2025;19(42):37065\u201381.","journal-title":"ACS Nano"},{"key":"4775_CR19","doi-asserted-by":"publisher","first-page":"107697","DOI":"10.1016\/j.exer.2019.107697","volume":"185","author":"I Luis de Redin","year":"2019","unstructured":"Luis de Redin I, et al. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization. Exp Eye Res. 2019;185:107697\u2013708.","journal-title":"Exp Eye Res"},{"issue":"11","key":"4775_CR20","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.1021\/acsnano.3c12203","volume":"18","author":"H Xu","year":"2024","unstructured":"Xu H, et al. Engineering Matrix-Free Drug Protein Nanoparticles with Promising Penetration through Biobarriers for Treating Corneal Neovascularization. ACS Nano. 2024;18(11):8209\u201328.","journal-title":"ACS Nano"},{"key":"4775_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.actbio.2022.09.029","volume":"153","author":"B Tang","year":"2022","unstructured":"Tang B, et al. Decorating hexahistidine-metal assemblies with tyrosine enhances the ability of proteins to pass through corneal biobarriers. Acta Biomater. 2022;153:231\u201342.","journal-title":"Acta Biomater"},{"issue":"1","key":"4775_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee J, et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem Theory Comput. 2016;12(1):405\u201313.","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"4775_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017;14(1):71\u20133.","journal-title":"Nat Methods"},{"issue":"3","key":"4775_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000268009","volume":"29","author":"C Laria","year":"1997","unstructured":"Laria C, Alio JL, Ruiz-Moreno JM. Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res. 1997;29(3):145\u201353.","journal-title":"Ophthalmic Res"},{"issue":"7","key":"4775_CR25","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1039\/D2MH00380E","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, et al. Remote drug loading into liposomes via click reaction. Mater Horiz. 2022;9(7):1969\u201377.","journal-title":"Mater Horiz"},{"key":"4775_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2147\/IJN.S154361","volume":"13","author":"C Yang","year":"2018","unstructured":"Yang C, et al. A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery. Int J Nanomed. 2018;13:1281\u201393.","journal-title":"Int J Nanomed"},{"key":"4775_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijbiomac.2020.02.116","volume":"151","author":"A Kaur","year":"2020","unstructured":"Kaur A, et al. Characterization of Cu(2+) and Zn(2+) binding sites in SUMO1 and its impact on protein stability. Int J Biol Macromol. 2020;151:204\u201311.","journal-title":"Int J Biol Macromol"},{"issue":"42","key":"4775_CR28","doi-asserted-by":"publisher","first-page":"22970","DOI":"10.1002\/anie.202110404","volume":"60","author":"Z Zou","year":"2021","unstructured":"Zou Z, et al. Zn(2+) -Coordination-Driven RNA Assembly with Retained Integrity and Biological Functions. Angew Chem Int Ed Engl. 2021;60(42):22970\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"Pt 5","key":"4775_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1107\/S0907444904004081","volume":"60","author":"MM Harding","year":"2004","unstructured":"Harding MM. The architecture of metal coordination groups in proteins. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 5):849\u201359.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"4775_CR30","doi-asserted-by":"crossref","unstructured":"Ramirez-Bello V et al. Zinc and Copper Ions Induce Aggregation of Human \u03b2-Crystallins. Molecules 2022;27(9):2970.","DOI":"10.3390\/molecules27092970"},{"issue":"2","key":"4775_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/acs.bioconjchem.8b00778","volume":"30","author":"D Pei","year":"2019","unstructured":"Pei D, Buyanova M. Overcoming Endosomal Entrapment in Drug Delivery. Bioconjug Chem. 2019;30(2):273\u201383.","journal-title":"Bioconjug Chem"},{"issue":"9","key":"4775_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528\u201342.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4775_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","volume":"18","author":"E Koren","year":"2012","unstructured":"Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med. 2012;18(7):385\u201393.","journal-title":"Trends Mol Med"},{"issue":"4","key":"4775_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/A:1009238717101","volume":"2","author":"B Vailh\u00e9","year":"1998","unstructured":"Vailh\u00e9 B, et al. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis. 1998;2(4):331\u201344.","journal-title":"Angiogenesis"},{"issue":"6","key":"4775_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376.","journal-title":"Nat Med"},{"issue":"5","key":"4775_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/gt.2008.185","volume":"16","author":"SR Singh","year":"2009","unstructured":"Singh SR, et al. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther. 2009;16(5):645\u201359.","journal-title":"Gene Ther"},{"issue":"12","key":"4775_CR37","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1167\/iovs.11-7871","volume":"52","author":"MH Dastjerdi","year":"2011","unstructured":"Dastjerdi MH, et al. Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci. 2011;52(12):8718\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4\u20135","key":"4775_CR38","first-page":"253","volume":"3","author":"W Noske","year":"1994","unstructured":"Noske W, et al. Tight junctions of the human corneal endothelium: morphological and electrophysiological features. Ger J Ophthalmol. 1994;3(4\u20135):253\u20137.","journal-title":"Ger J Ophthalmol"},{"key":"4775_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","volume":"126","author":"A Mandal","year":"2018","unstructured":"Mandal A, et al. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. Adv Drug Deliv Rev. 2018;126:67\u201395.","journal-title":"Adv Drug Deliv Rev"},{"key":"4775_CR40","doi-asserted-by":"publisher","first-page":"120873","DOI":"10.1016\/j.ijpharm.2021.120873","volume":"606","author":"B Silva","year":"2021","unstructured":"Silva B, et al. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery. Int J Pharm. 2021;606:120873.","journal-title":"Int J Pharm"},{"key":"4775_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/IJN.S398769","volume":"18","author":"YC Chu","year":"2023","unstructured":"Chu YC, et al. Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment. Int J Nanomed. 2023;18:1413\u201331.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4775_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12951-024-02499-0","volume":"22","author":"W Zhang","year":"2024","unstructured":"Zhang W, et al. Dual-ROS-scavenging and dual-lingering nanozyme-based eye drops alleviate dry eye disease. J Nanobiotechnol. 2024;22(1):229.","journal-title":"J Nanobiotechnol"},{"key":"4775_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.phrs.2015.11.027","volume":"103","author":"M Amadio","year":"2016","unstructured":"Amadio M, Govoni S, Pascale A. Targeting VEGF in eye neovascularization: What\u2019s new? A comprehensive review on current therapies and oligonucleotide-based interventions under development. Pharmacol Res. 2016;103:253\u201369.","journal-title":"Pharmacol Res"},{"key":"4775_CR44","doi-asserted-by":"crossref","unstructured":"Goncharov NV et al. Markers of Endothelial Cells in Normal and Pathological Conditions. Biochem (Mosc) Suppl Ser A Membr Cell Biol, 2020. 14(3): pp. 167\u2013183.","DOI":"10.1134\/S1990747819030140"},{"issue":"5","key":"4775_CR45","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/CIRCRESAHA.110.218396","volume":"107","author":"H Kim","year":"2010","unstructured":"Kim H, et al. CD31\u2009+\u2009cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31\u2009+\u2009cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res. 2010;107(5):602\u201314.","journal-title":"Circ Res"},{"issue":"1","key":"4775_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/ATVBAHA.109.194233","volume":"30","author":"MB Nourse","year":"2010","unstructured":"Nourse MB, et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol. 2010;30(1):80\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"4775_CR47","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1091\/mbc.11.5.1687","volume":"11","author":"SW Ryeom","year":"2000","unstructured":"Ryeom SW, Paul D, Goodenough DA. Truncation mutants of the tight junction protein ZO-1 disrupt corneal epithelial cell morphology. Mol Biol Cell. 2000;11(5):1687\u201396.","journal-title":"Mol Biol Cell"},{"key":"4775_CR48","doi-asserted-by":"publisher","first-page":"100143","DOI":"10.1016\/j.mtbio.2021.100143","volume":"12","author":"H Xu","year":"2021","unstructured":"Xu H, et al. Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model. Mater Today Bio. 2021;12:100143.","journal-title":"Mater Today Bio"},{"key":"4775_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.actbio.2025.02.006","volume":"196","author":"B Mao","year":"2025","unstructured":"Mao B, et al. A promising strategy for ocular noninvasive protein delivery: The case in treating corneal neovascularization. Acta Biomater. 2025;196:307\u201320.","journal-title":"Acta Biomater"},{"issue":"1\u20132","key":"4775_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2018.09.017","volume":"552","author":"X Xu","year":"2018","unstructured":"Xu X, et al. Prevention of corneal neovascularization by subconjunctival injection of avastin\u00ae loaded thermosensitive hydrogels in rabbit model. Int J Pharm. 2018;552(1\u20132):164\u201370.","journal-title":"Int J Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04775-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:34:10Z","timestamp":1791239650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04775-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4775"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04775-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"928"}}